Medivance Inc. recalls Medivance Neonatal ArcticGel Pads
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Neonatal pads are experiencing reduced water flow, which may reduce or prevent water heating or cooling performance of the pads that are part of a temperature management system.
- Products
-
- Medivance Neonatal ArcticGel Pads
- Company
- Medivance Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution including in the states of IL, AL, AZ, CA, CO, CT, DC, DE, FL, GA, IA, ID, IN, KS, KY, LA, MA, MD, MI, MN, MO, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SD, TN, TX, UT, VA, WA, WI, WV and the countries of Belgium, Australia, Singapore, South Korea, Taiwan, Japan, China, Thailand.
Nationwide
- Units affected
- 1,654
- About this recall
- Medivance Neonatal ArcticGel Pads, REF: 31802, 3180202, 31802C